| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $276,482,115 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | T32HD007470 | Predoctoral Training in Developmental Biology | 000 | 32 | NIH | 4/20/2026 | $339,201 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | T32GM156671 | UCSF IMSD | 000 | 2 | NIH | 1/16/2026 | $359,826 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | T32HD049303 | Research Training in Pediatric Critical Care Medicine | 000 | 20 | NIH | 4/22/2026 | $177,408 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R56AG046400 | Linking metabolism, neural function, and aging | 000 | 11 | NIH | 12/29/2025 | $537,590 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R61CA278518 | Quantitative analysis and manipulation of chromosome dynamics in cancer organoids | 001 | 3 | NIH | 4/16/2026 | $22,650 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R61CA278518 | Quantitative analysis and manipulation of chromosome dynamics in cancer organoids | 000 | 3 | NIH | 1/12/2026 | $203,855 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R56DE028891 | Sjogren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen) | 000 | 6 | NIH | 5/4/2026 | $492,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | RC2DK136052 | Establishing patient-derived iPSCs as a platform for discovery research in NAFLD | 000 | 4 | NIH | 4/15/2026 | $1,614,997 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | U19AI077439 | Immune-driven Airway Epithelial Dysfunction in Muco-obstructive Asthma | 000 | 19 | NIH | 4/9/2026 | $1,410,836 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | U01NS146166 | Prenatal AAV9 gene replacement therapy for patients with severe infantile GM1 gangliosidosis | 000 | 1 | NIH | 3/23/2026 | $649,600 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U19AI166798 | Molecules and Pathways at the Coccidioides Host-Pathogen Interface | 000 | 5 | NIH | 1/21/2026 | $1,736,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01DE033953 | Economic Stressors and Opportunities as Influences of Emerging Adult Oral Health | 001 | 3 | NIH | 4/30/2026 | $647,819 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01DK119100 | UCSF Diabetic Foot Clinical Research Unit | 000 | 8 | NIH | 1/19/2026 | $608,183 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01DK119100 | UCSF Diabetic Foot Clinical Research Unit | 000 | 8 | NIH | 1/19/2026 | $171,865 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01HG014145 | Enhancing Access to Genomic Expertise: A Comprehensive Implementation Strategy for the Western Regional Genomic eConsult Network (WestGEN) | 001 | 1 | NIH | 5/5/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U01HG014145 | Enhancing Access to Genomic Expertise: A Comprehensive Implementation Strategy for the Western Regional Genomic eConsult Network (WestGEN) | 000 | 1 | NIH | 2/27/2026 | $2,825,743 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | T32MD015070 | UCSF Data Science Training to Advance Behavioral and Social Science Expertise for Health Research (DaTABASE) Program | 001 | 7 | NIH | 5/12/2026 | $461,850 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | T32MH019105 | Traineeships in AIDS Prevention Studies | 002 | 38 | NIH | 4/29/2026 | $554,309 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U24NS107229 | NIH StrokeNet- NorCal Regional Coordinating Center RCC13 | 001 | 8 | NIH | 4/8/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U24NS107229 | NIH StrokeNet- NorCal Regional Coordinating Center RCC13 | 000 | 8 | NIH | 12/23/2025 | $374,156 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U19AI135990 | HPMI: Host Pathogen Mapping Initiative | 000 | 8 | NIH | 4/28/2026 | $2,452,655 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U19AI089674 | Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal | 002 | 17 | NIH | 5/12/2026 | $590,328 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | U19AI089674 | Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal | 001 | 17 | NIH | 4/30/2026 | $276,880 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY038172 | Adalimumab Dose Adjustment for Pediatric uveitis Treatment (ADAPT) Trial | 001 | 1 | NIH | 5/7/2026 | $7,400 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 000 | 1 | NIH | 5/11/2026 | $492,815 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY038172 | Adalimumab Dose Adjustment for Pediatric uveitis Treatment (ADAPT) Trial | 000 | 1 | NIH | 4/27/2026 | $1,655,047 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY033703 | Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) Trial | 001 | 4 | NIH | 5/7/2026 | $14,580 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY033703 | Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) Trial | 000 | 4 | NIH | 4/23/2026 | $1,068,539 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY033292 | NAC Attack AOSLO Reading Center | 000 | 5 | NIH | 4/1/2026 | $206,659 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG3AG090679 | Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA) | 002 | 2 | NIH | 4/21/2026 | $142,090 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1HD112092 | Maternal Fetal Medicine Units Network: University of California, San Francisco | 000 | 4 | NIH | 4/7/2026 | $355,300 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG3AG090679 | Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA) | 001 | 2 | NIH | 4/20/2026 | $132,511 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG3AG090679 | Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA) | 000 | 2 | NIH | 4/2/2026 | $233,728 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UH3NS119702 | FOcal Cerebral Arteriopathy Steroids (FOCAS) Trial | 000 | 4 | NIH | 2/23/2026 | $1,535,323 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UH3NS128297 | Cerebellar deep brain stimulation for severe combined movement disorders and spasticity in children and young adults with cerebral palsy | 000 | 3 | NIH | 4/17/2026 | $959,582 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UM1AI069436 | UZ-UCSF CTU | 003 | 20 | NIH | 4/30/2026 | $570,121 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UM1AI069436 | UZ-UCSF CTU | 002 | 20 | NIH | 1/28/2026 | $1,499,619 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UM1AI069436 | UZ-UCSF CTU | 001 | 20 | NIH | 1/16/2026 | $477,732 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UM1AI069436 | UZ-UCSF CTU | 000 | 20 | NIH | 10/1/2025 | -$60,252 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UM1AI179699 | Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium | 000 | 3 | NIH | 1/30/2026 | $5,200,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UM1AI179699 | Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium | 000 | 3 | NIH | 1/30/2026 | $2,000,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UE5GM157550 | ARC UE5 at the University of California San Francisco | 000 | 2 | NIH | 3/27/2026 | $378,522 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UC2DE032254 | Sjögren’s Team for Accelerating Medicines Partnership (STAMP) | 001 | 5 | NIH | 4/6/2026 | $350,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UC2DE032254 | Sjögren’s Team for Accelerating Medicines Partnership (STAMP) | 001 | 5 | NIH | 4/6/2026 | $600,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UC2DE032254 | Sjögren’s Team for Accelerating Medicines Partnership (STAMP) | 000 | 5 | NIH | 2/10/2026 | $1,000,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG3DK142187 | Stem cell-based modeling of type 1 diabetes to accelerate translation of therapies | 000 | 2 | NIH | 1/20/2026 | $1,087,589 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG3NS146003 | Multisite closed loop DBS for Chronic Pain | 000 | 1 | NIH | 4/21/2026 | $387,647 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UH3DA058304 | Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV. | 000 | 4 | NIH | 4/24/2026 | $875,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UH3DA058304 | Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV. | 000 | 4 | NIH | 4/24/2026 | $912,418 |
|
